Jill Marie Broadfoot - Jun 4, 2025 Form 4 Insider Report for Cue Biopharma, Inc. (CUE)

Role
Director
Signature
/s/ Jill Marie Broadfoot by Colin Sandercock, attorney-in-fact
Stock symbol
CUE
Transactions as of
Jun 4, 2025
Transactions value $
$0
Form type
4
Date filed
6/6/2025, 04:00 PM
Previous filing
Feb 4, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Broadfoot Jill Marie Director C/O CUE BIOPHARMA, INC., 40 GUEST STREET, BOSTON /s/ Jill Marie Broadfoot by Colin Sandercock, attorney-in-fact 2025-06-06 0001305178

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CUE Stock Option (right to buy) Award $0 +48.8K $0.00 48.8K Jun 4, 2025 Common Stock 48.8K $0.62 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.
F2 This option was granted on June 4, 2025. The shares underlying the option are scheduled to vest over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments.